Invention Grant
![Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors](/docs/US/2017-08-29/US09745311B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
-
Application No.: US15181903Application Date: 2016-06-14
-
Publication No.: US09745311B2Publication Date: 2017-08-29
- Inventor: Liang Lu , Chunhong He , Wenqing Yao
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D495/04 ; C07D519/00
![Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors](/abs-image/US/2017/08/29/US09745311B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to pyrazine derivatives of Formula I, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Public/Granted literature
- US20160280713A1 PYRAZINE DERIVATIVES AS FGFR INHIBITORS Public/Granted day:2016-09-29
Information query
